跳至主要内容
临床试验/EUCTR2012-003192-19-ES
EUCTR2012-003192-19-ES进行中(未招募)1 期

Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial - Haemorrhage alleviation with tranexamic acid- intestinal system[HALT-IT] [Version 1.0]

ondon School Of Hygiene and Tropical Medicine0 个研究点目标入组 8,000 人开始时间: 2016年3月18日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
8,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • ? Adult (18 years and over) with significant gastrointestinal bleeding
  • ? Where the responsible clinician is substantially uncertain as to whether or not to use tranexamic acid
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 200
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 3800
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 4000

排除标准

  • ? Patients for whom the responsible clinician considers there is a clear indication for tranexamic acid.
  • ? Patients for whom the responsible clinician considers there is a clear contraindication for tranexamic acid.

研究者

发起方
ondon School Of Hygiene and Tropical Medicine

相似试验

Tranexamic Acid for the treatment of significant... | 临床试验